OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-12.5

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
$1.1508per EA

Strength

5; 12.5; 40 mg/1; mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884078711

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206137

On Market Since

10/26/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+2.3%

3M

-12.8%

6M

-13.7%

1Y

-4.9%

3Y

-18.4%

5Y

-53.3%

All

-64.5%